您要查找的是不是：
- The recovery from neutropenia is also important for the treatment of DFI. 原發(fā)病的緩解及粒細胞恢復也是真菌感染能否治愈的重要因素。
- When the white blood cell count becomes too low, it is called Neutropenia. 白血球減少癥。治療白血球減少癥時(shí)，可能需要輸白血球。
- SMZ-TMP Deputy reaction neutropenia, fever, rash and liver toxicity. SMZ-TMP副反應有白細胞減少、發(fā)熱、皮疹和肝毒性。
- Hereditary neutropenia (or trapped neutrophil syndrome TNS) is a more recently described disease in Border Collies. 遺傳性嗜中性白血球減少癥（又稱(chēng)嗜中性白細胞困阻癥,TNS)是一種新近在邊境牧羊犬中發(fā)現的疾病。
- Superinfection was related with the age of patients, hypoimmunity, extensive usage of the antibiotics and neutropenia. 二重感染的發(fā)生與年齡、機體免疫力低下、抗生素的廣泛使用及粒細胞減少有關(guān)。
- Toxicity was primarily hematologic and inoled neutropenia, thrombocytopenia and anemia. 最初的血液學(xué)毒性包括嗜中性白血球減少、血小板減少和貧血。
- The most commonly-reported reactions were neutropenia (457 reports), pyrexia (276), and tachycardia (259). 最常見(jiàn)的不良反應是中性粒細胞減少癥（457例），發(fā)熱（276例），和心動(dòng)過(guò)速（259例）。
- There was no association between the other exposures and leucopenia or neutropenia. 其馀的職業(yè)暴露和白血球減少并無(wú)顯著(zhù)的相關(guān)性。
- One of them suffered from neutropenia and the other 7 cases were with defect in immunoglobulin production. 其中1癥例是中性白血球不足，另外7癥例是全部或部份免疫球蛋白不足或缺乏。
- Two colony-stimulating factors (G-CSF and GM-CSF) approved to fight the neutropenia of cancer treatment. 批準兩種集落刺激因子(G-CSF和GM-CSF)控制癌治療相關(guān)的中性粒細胞減少.
- It also may be used as empiric therapy for presumed fungus infection in patients with fever and neutropenia. 也可以用于白細胞減少發(fā)熱病人中懷疑可能有真菌感染的經(jīng)驗性用藥。
- Two colony-stimulating factors (G-CSF and GM-CSF) approed to fight the neutropenia of cancer treatment. 批準兩種集落刺激因子(G-CSF和GM-CSF)控制癌治療相關(guān)的中性粒細胞減少.
- Especially demanding of broad-spectrum antibiotics are patients with profound neutropenia (< 500 cells per cu m). 特別是對那些伴有嚴重中性白細胞減少的患兒更需要使用廣譜抗生素。
- The infection is well documented in other immunocompromised states such as leukaemia, post-chemotherapy neutropenia and occult malignancies, often colonic. 這種感染多見(jiàn)于一些免疫抑制狀態(tài)，例如白血癥，化療后中性粒細胞減少及結腸癌等隱性惡性腫瘤。
- OBJECTIVE To compare the effects of ceftazidime alone or with vancomycin in the treatment of febrile neutropenia in the children with cancers. 目的比較頭孢他啶單用與聯(lián)用萬(wàn)古霉素對治療發(fā)熱性中性粒細胞減少癥血液腫瘤患兒的療效。
- Methods The clinical data of empirical antibiotic therapy with imipenem in 51 cancer patients with febrile neutropenia were analyzed retrospectively. 方法回顧性分析51例腫瘤患者化療后出現中性粒細胞缺乏伴發(fā)熱應用亞胺培南進(jìn)行經(jīng)驗性治療的臨床資料。
- There were thrombocytosis in 34 cases(44.2%), neutropenia in 28(36.3%),anema in 12(15.6%),thrombocytopenia in 2(2.6%) and pancytopenia in 1(1.3%). 主要有外周血血小板增多34例(44.;2%25);粒細胞減少癥28例(36
- All patients were less than twelve months old and the majority presented with sepsis, diarrhea, ecthyma gangrenosum, and neutropenia. 這些兒童之特徵包括年紀小于一歲，表現出腹瀉及敗血癥，壞死性膿瘡，以及嗜中性白血球減少。
- The major toxicity associated with paclitaxel included neutropenia,myalgia,arthralgia,numbness of hands and feet and alopecia. 主要不良反應為白細胞減少、肌肉及關(guān)節疼痛、手足麻木和脫發(fā)。
- Background: TAC (docetaxel/doxorubicin/cyclophosphamide) is associated with high incidences of grade 4 neutropenia and febrile neutropenia (FN). 背景：TAC方案（紫杉醇/阿霉素/環(huán)磷酰胺）常會(huì )造成4級中性粒細胞減少和由于中性減少而引起的發(fā)熱（FN）。
